NY-ESO-1TCR Engineered Adoptive Cell Transfer Therapy with CTLA4 Blockade - Stand Up To Cancer

Blog

Posted October 14, 2019

NY-ESO-1TCR Engineered Adoptive Cell Transfer Therapy with CTLA4 Blockade

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.